# Cosopt Versus Xalacom

> **NCT00273481** · PHASE4 · COMPLETED · sponsor: **Pharmaceutical Research Network** · enrollment: 33 (—)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** dorzolamide 2%/timolol maleate 0.5% fixed combination
- **DRUG:** latanoprost 0.005%/timolol maleate 0.5% fixed combination
- **DRUG:** timolol maleate 0.5%
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00273481
- **Lead sponsor:** Pharmaceutical Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 33 (—)
- **Last updated:** 2008-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273481, "Cosopt Versus Xalacom". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00273481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*